MEP20108A - Sferni aglomjerati telitromicina, postupak za njihovo dobijanje i njihova primjena u dobijanju farmaceutskih oblčika - Google Patents

Sferni aglomjerati telitromicina, postupak za njihovo dobijanje i njihova primjena u dobijanju farmaceutskih oblčika

Info

Publication number
MEP20108A
MEP20108A MEP-201/08A MEP20108A MEP20108A ME P20108 A MEP20108 A ME P20108A ME P20108 A MEP20108 A ME P20108A ME P20108 A MEP20108 A ME P20108A
Authority
ME
Montenegro
Prior art keywords
preparation
production
pharmaceutical forms
telithromycin
spherical
Prior art date
Application number
MEP-201/08A
Other languages
English (en)
Inventor
Jean-Yves Godard
Valerie Rognon
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9549351&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP20108(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of MEP20108A publication Critical patent/MEP20108A/bs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Pronalazak ima za objekat sferne aglomerate telitromicina. Pronalazak ima takođe za objekat postupak dobijanja sfernih aglomerata telitromicina, okarakterisan time što se priprema supsenzija kristala faze koja je nerastvorna u telitromicinu koja kristališe brzo. Sferni aglomerati pronalaska nalaze svoju primjenu u pripremanju mikrokapsula.
MEP-201/08A 1999-08-26 2000-08-28 Sferni aglomjerati telitromicina, postupak za njihovo dobijanje i njihova primjena u dobijanju farmaceutskih oblčika MEP20108A (bs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9910810A FR2797875B1 (fr) 1999-08-26 1999-08-26 Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques
PCT/FR2000/002393 WO2001014393A2 (fr) 1999-08-26 2000-08-28 Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques

Publications (1)

Publication Number Publication Date
MEP20108A true MEP20108A (bs) 2010-06-10

Family

ID=9549351

Family Applications (2)

Application Number Title Priority Date Filing Date
MEP-201/08A MEP20108A (bs) 1999-08-26 2000-08-28 Sferni aglomjerati telitromicina, postupak za njihovo dobijanje i njihova primjena u dobijanju farmaceutskih oblčika
MEP-2008-201A ME00112B (me) 1999-08-26 2000-08-28 Sferni aglomerati telitromicina,postupak za njihovo dobijanje i njihova primena u dobijanju farmaceutskih oblika

Family Applications After (1)

Application Number Title Priority Date Filing Date
MEP-2008-201A ME00112B (me) 1999-08-26 2000-08-28 Sferni aglomerati telitromicina,postupak za njihovo dobijanje i njihova primena u dobijanju farmaceutskih oblika

Country Status (34)

Country Link
US (1) US6825218B1 (bs)
EP (1) EP1212336B1 (bs)
JP (1) JP4871467B2 (bs)
KR (1) KR100718222B1 (bs)
CN (1) CN1183151C (bs)
AR (1) AR025398A1 (bs)
AT (1) ATE255590T1 (bs)
AU (1) AU774385B2 (bs)
BR (1) BR0013569B1 (bs)
CA (1) CA2382497C (bs)
CO (1) CO5190666A1 (bs)
CZ (1) CZ2002594A3 (bs)
DE (1) DE60006976T2 (bs)
DK (1) DK1212336T3 (bs)
EA (1) EA005080B1 (bs)
ES (1) ES2209970T3 (bs)
FR (1) FR2797875B1 (bs)
HK (1) HK1049167B (bs)
HR (1) HRP20020167B1 (bs)
HU (1) HU229075B1 (bs)
IL (2) IL148128A0 (bs)
ME (2) MEP20108A (bs)
MX (1) MXPA02001988A (bs)
NO (1) NO322622B1 (bs)
PL (1) PL204100B1 (bs)
PT (1) PT1212336E (bs)
RS (1) RS50433B (bs)
SI (1) SI1212336T1 (bs)
SK (1) SK287588B6 (bs)
TR (1) TR200200506T2 (bs)
TW (1) TWI272949B (bs)
UA (1) UA73523C2 (bs)
WO (1) WO2001014393A2 (bs)
ZA (1) ZA200201599B (bs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902202D0 (sv) * 1999-06-10 1999-06-10 Astra Ab Production of aggregates
FR2821747B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Suspension de telithromycine a gout masque
BR0215806A (pt) * 2002-07-19 2005-04-26 Aventis Pharma Sa Composição oral de telitromicina com paladar mascarado
WO2004009059A1 (en) * 2002-07-19 2004-01-29 Aventis Pharma S.A. Taste masked oral composition of telithromycin
US20040013737A1 (en) * 2002-07-19 2004-01-22 Philippe Becourt Taste masked oral composition of telithromycin
EP1610878B1 (en) * 2003-02-21 2014-09-03 University Of Bath Process for the production of particles
WO2005007143A2 (en) * 2003-07-14 2005-01-27 The Board Of Trustees Of The University Of Illinois Use of makrolides and ketolides for the treatment of tuberculosis
WO2007039914A2 (en) * 2005-10-06 2007-04-12 Alembic Limited Novel polymorphs of telithromycin
US20090075917A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched telithromycin
KR101324862B1 (ko) * 2011-07-12 2013-11-01 (주)에이에스텍 클로피도그렐 황산수소염의 구형 입자, 이를 포함하는 약학적 조성물 및 이의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3468336D1 (en) * 1983-06-22 1988-02-11 Univ Ohio State Res Found Small particle formation
JPH02227130A (ja) * 1989-02-28 1990-09-10 Taisho Pharmaceut Co Ltd 球形微小凍結粒子の製造法
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
AU7018100A (en) 2001-03-19
CA2382497C (fr) 2011-06-28
CZ2002594A3 (cs) 2002-09-11
SK287588B6 (sk) 2011-03-04
SK2532002A3 (en) 2002-09-10
HK1049167B (zh) 2005-08-19
US6825218B1 (en) 2004-11-30
FR2797875B1 (fr) 2001-10-19
IL148128A (en) 2006-10-31
ATE255590T1 (de) 2003-12-15
UA73523C2 (uk) 2005-08-15
HUP0202842A3 (en) 2003-03-28
WO2001014393A3 (fr) 2001-06-21
KR100718222B1 (ko) 2007-05-15
NO20020926L (no) 2002-02-26
DK1212336T3 (da) 2004-03-15
CN1183151C (zh) 2005-01-05
DE60006976T2 (de) 2004-10-21
PL353137A1 (en) 2003-10-20
KR20020033771A (ko) 2002-05-07
HUP0202842A2 (hu) 2003-01-28
JP4871467B2 (ja) 2012-02-08
YU13202A (sh) 2004-09-03
CO5190666A1 (es) 2002-08-29
CA2382497A1 (fr) 2001-03-01
CN1371386A (zh) 2002-09-25
BR0013569A (pt) 2002-05-14
ME00112B (me) 2010-10-10
RS50433B (sr) 2009-12-31
ES2209970T3 (es) 2004-07-01
AR025398A1 (es) 2002-11-27
TR200200506T2 (tr) 2002-08-21
EA005080B1 (ru) 2004-10-28
MXPA02001988A (es) 2002-08-20
PT1212336E (pt) 2004-04-30
HK1049167A1 (en) 2003-05-02
ZA200201599B (en) 2003-04-30
HRP20020167B1 (en) 2006-06-30
DE60006976D1 (de) 2004-01-15
WO2001014393A2 (fr) 2001-03-01
TWI272949B (en) 2007-02-11
FR2797875A1 (fr) 2001-03-02
PL204100B1 (pl) 2009-12-31
IL148128A0 (en) 2002-09-12
EP1212336A2 (fr) 2002-06-12
HU229075B1 (hu) 2013-07-29
BR0013569B1 (pt) 2014-02-25
NO20020926D0 (no) 2002-02-26
HRP20020167A2 (en) 2003-06-30
SI1212336T1 (en) 2004-04-30
EP1212336B1 (fr) 2003-12-03
NO322622B1 (no) 2006-11-06
AU774385B2 (en) 2004-06-24
JP2003507484A (ja) 2003-02-25
EA200200294A1 (ru) 2002-08-29

Similar Documents

Publication Publication Date Title
CY1109874T1 (el) Σταθερο κρυσταλλικο αλας του 5-μεθυλο-(6s)τετραϋδροφολικου οξεος
YU13202A (sh) Sferni aglomerati telitromicina, postupak za njihovo dobijanje i njihova primena u dobijanju farmaceutskih oblika
CA2481848A1 (en) Active ingredient particles carrying clopidogrel or a salt thereof, their use and method of preparation
FR2811320B1 (fr) Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
DK0991653T3 (da) Nye forbindelser
CA2067221A1 (en) Fused pyrimidine derivative, process for preparation of same and pharmaceutical preparation comprising same as active ingredient
BRPI0417043A (pt) composição farmacêutica, forma de dosagem sólida, método de manufatura de forma de dosagem sólida, e, uso da composição
FR2811318B1 (fr) Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
EE200100161A (et) Segamisest sõltumatud toimeainet aeglustatult vabastavad mitmeosalised ravimvormid ja nende valmistamismeetodid
IL88370A0 (en) Process for the production of biodegradable microcapsules of water-soluble peptides and proteins,and microcapsules obtained by this process
CA2187409A1 (en) Stable Crystalline Tetrahydrofolic Acid Salts
DE60100500D1 (de) Suspension enthaltend ein epi-hne protein, verfahren zu ihrer herstellung, daraus hergestelltes trockenpulveraerosol, arzneimittelzusammensetzungen enthaltend diese suspension oder dieses aerosol und ihre verwendungen
AU2838001A (en) Method for the production of protein preparations with essentially constant properties with regard to solubility and functionality within a ph range from about ph 3 to ph 10
HUP0300154A3 (en) Method for the production of spirocyclic tetronic acid derivatives
IT9067649A0 (it) Procedimento di produzione di formulazioni enzimatiche acquose
DE60203997D1 (de) Nasses granulationsverfahren zur herstellung von pharmazeutischen tabletten mit paroxetinhydrochlorid anhydrat
NO20021269L (no) Fremgangsmåte for fremstilling av metylenbisfosfonsyrer og salter
WO2002044346A3 (de) Stammzellen, verfahren zu deren expansion in vitro sowie deren verwendung
IS3947A (is) Amínósýru afleiður, aðferð til framleiðslu þeirraog notkunar sem lyfja
IT1165465B (it) Forma microcristallina dell'isoxicam procedimento per ottenerla e composizioni farmaceutiche che la contengono
EP1176137A4 (en) Powdery s,s-ethylenediamine-n,n'-disuccinic acid iron complex and process for producing the same
IT1284030B1 (it) Metodo per la produzione di sospensioni acquose stabili, utili nelle composizioni farmaceutiche
KR900011443A (ko) 흡착성 구상 왁스 분말의 제조방법
HUP9903371A3 (en) Carboxylic acid derivatives, their production and use of them for producing pharmaceutical compositions
RU2000112951A (ru) Способ лечения гифемы